Valmet to Acquire Tissue Rewinder Business from Massimiliano Corsini
Print this Article | Send to Colleague
Valmet, Finland, this week agreed to purchase the Massimiliano Corsini, Italy, MC Paper Machinery and Focus Rewinding business. The acquisition is estimated to be completed by today (August 6).
The acquired operations mainly supply rewinders for tissue and non-woven machines. In the past years, the net sales of the acquired business has been around EUR 10 million. The operations employ 33 people and are located in Pescia, close to Lucca, Italy.
As a result of the acquisition, Valmet will have a more extensive product portfolio and becomes a stronger technology and services company in its field. The acquisition strengthens Valmet's competitiveness by combining tissue making equipment from stock preparation to rewinding, process know-how, automation, and services into one customer value-adding entity.
Valmet and MC Paper Machinery have had a long-term partnership and a large amount of MC Paper rewinders have been installed in connection with Valmet tissue machines.
The company being acquired is a strong business, with established customer relations and a high level of technology and know-how, including the successful Focus technology. During the past 20 years, MC Paper Machinery has become world leading in designing and manufacturing rewinding plants specifically devoted to the field of non-woven and tissue paper, according to Valmet.
Through the acquisition, Valmet strengthens its offering and continues to develop its business.
"Valmet and MC Paper Machinery share the same determination to offer leading technologies, with highest customer satisfaction. Through the acquisition, Valmet will become a technology and service company with a wider offering of high technology equipment for tissue production. By combining tissue paper and re-winding machinery with process know-how, automation, and services and global presence from both companies, we can serve the tissue producers even better than before and move our customers' performance forward," said Anders Björn, VP of Valmet's Tissue Mills Business Unit.
